RTM program · Neurology

Multiple sclerosis

Disability accrues between visits, and visits are two a year.

MS is managed on a schedule that does not match the disease. Two visits a year and an annual MRI cannot detect the slow functional drift that becomes permanent disability, and they certainly cannot detect a patient who quietly stopped their therapy in March. Continuous functional measurement is not a replacement for imaging. It is the thing that tells you when to look.
Multiple sclerosis · observed transmission profile Representative, not best case
Day 1Day 15Day 30
Transmitted days 0 / 30
Device supply code
Signal stack

What gets measured, from where, and why it earns its place

Every source is tagged at ingest as billable or context-only. Context-only data is clinically valuable and never enters a device-supply line.

Gait and mobility
Passive phone-based gait cadence and variability, plus timed walk
Gait variability shifts before a patient reports a change. Passive collection avoids asking a fatigued person to perform tasks.
Manual dexterity
Screen-based tapping and tracing tasks, weekly
A remote analogue of the nine-hole peg concept. Sensitive to upper-limb progression.
Fatigue and cognition
Weighted weekly inventory plus processing speed task
Fatigue is the most disabling symptom by patient report and the least captured in the record.
Therapy adherence
Structured logging by route, oral or injectable or infusion schedule
Persistence on disease-modifying therapy is the primary determinant of long-term disability and drops off silently.
Relapse self-report
Structured, event-triggered
Time from symptom onset to clinical contact is the modifiable variable in relapse management.
Escalation design

Thresholds, and who has to do something about them

Red marks a same-day or immediate pathway. Amber marks a review within the stated window. Each one is assigned to a named clinician with a response clock, not to a queue.

New focal symptom reported
ResponseSame-day contact, relapse pathway
Gait variability rising across 14 days
ResponseClinical review
Two or more missed oral doses in a week
ResponseAdherence contact
Processing speed decline across two assessments
ResponseCognitive review

What we will not oversell

Remote functional measures are not validated disability scales. Gathermed reports them as within-patient trajectories and explicitly does not output an EDSS estimate. Do not let a sponsor talk you into implying otherwise.

Program operation

How the month actually runs

Baseline functional battery at enrollment, ideally at a stable visit rather than post-relapse.
Passive gait collection continuously, active tasks weekly, inventories weekly.
Trajectory review before each scheduled visit so the visit starts with data rather than recall.
Relapse self-report routes same-day with a defined steroid decision pathway.
Management time and interactive communication monthly.
Code path · CY2026

What this program can bill

Rates are national non-facility averages, rounded, for orientation. They vary by locality and payer. Verify against your fee schedule before you model revenue on them.

CodeWhat it coversNational avgCadence
98975Setup and patient education
One-time setup and education on use of the monitoring equipment.
$21.71once per episode
98978Device supply, cognitive behavioral therapy, 16-30 days
Device supply for cognitive behavioral therapy monitoring, 16 or more days of data in 30.
$39.75per 30 days
98986new 2026Device supply, cognitive behavioral therapy, 2-15 days
New for 2026. Short-duration CBT device supply. Mutually exclusive with 98978.
$39.75per 30 days
98980Treatment management, first 20 min
20 minutes of QHP management time with at least one interactive communication.
$53.77per calendar month
98979new 2026Treatment management, first 10 min
New for 2026. 10 to 19 minutes of management time with at least one interactive communication. Mutually exclusive with 98980.
$26.05per calendar month
98981Treatment management, each additional 20 min
Add-on to 98980. Reported per additional 20 minutes in the month.
$41.8per additional 20 min

Diagnosis anchors

ICD-10-CMDescription
G35Multiple sclerosis

Illustrative anchors only. Code to the documented clinical picture, not to a list on a vendor website.

The rules that break programs

One billing clinician per 30-day episode. RPM and RTM are not additive in the same calendar month. Duration codes are mutually exclusive. Management time requires at least one real-time interactive communication. Medical necessity precedes enrollment.

Full rule set and calculator

Sponsor view

If you are a manufacturer looking at this condition

A strong sponsored case with an unusually direct commercial logic. Disease-modifying therapy persistence is the core commercial metric in MS and current visibility is limited to refill data. A program yields persistence curves with structured stop reasons, functional trajectory on therapy at a resolution no registry achieves, and relapse timing relative to adherence gaps. Relevant to every DMT class and to any program trying to demonstrate a progression benefit outside of imaging endpoints.

Read this before you fund anything

Sponsor-funded monitoring that produces billable revenue for prescribers is remuneration to referral sources under the federal Anti-Kickback Statute. The structures that survive scrutiny keep the sponsor's data interest and the provider's billing interest completely separate. The three structures we will build, and the one we will not.

Questions

Multiple sclerosis monitoring, answered directly

Can remote monitoring replace the neurology visit?
No, and a program that markets itself that way will fail clinically and commercially. It changes what the visit is for, from reconstructing six months by memory to deciding what to do about a trajectory everyone can see.